Barclays Maintains an 'Overweight' on Liberty Global (LBTYA); After KBW, Are Sights Set on the Netherlands?
Get Alerts LBTYA Hot Sheet
Price: $16.93 +1.87%
Rating Summary:
11 Buy, 9 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 1
Rating Summary:
11 Buy, 9 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 1
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Liberty Global (NASDAQ: LBTYA), PT $48.
Barclays analyst says, "LGI is clearly increasing its focus on Europe, with an announced deal in Germany (KBW) and press reports of a potential, and larger, acquisition in the Netherlands (Ziggo). We view the KBW deal as strategically attractive and valuation as reasonable; the deal is compatible with the company's buyback targets. Ziggo would make a much larger target; although strategic logic (consolidation of Dutch operations) is sound, a potential deal would likely face materially higher financing and regulatory challenges."
For more ratings news on Liberty Global click here and for the rating history of Liberty Global click here.
Shares of Liberty Global closed at $42.70 yesterday.
Barclays analyst says, "LGI is clearly increasing its focus on Europe, with an announced deal in Germany (KBW) and press reports of a potential, and larger, acquisition in the Netherlands (Ziggo). We view the KBW deal as strategically attractive and valuation as reasonable; the deal is compatible with the company's buyback targets. Ziggo would make a much larger target; although strategic logic (consolidation of Dutch operations) is sound, a potential deal would likely face materially higher financing and regulatory challenges."
For more ratings news on Liberty Global click here and for the rating history of Liberty Global click here.
Shares of Liberty Global closed at $42.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Liberty Media in Exclusive Talks to Buy Dorna Sports For EUR 4B - FT
- Oppenheimer Starts Immunovant (IMVT) at Outperform, 'expect the execution to unlock considerable value'
- Westport Innovations (WPRT) PT Lowered to $9 at RBC Capital
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!